On November 18, 2019, the Gladstone Institutes and UCSF hosted Dr. Antonio Lanzavecchia, who presented a seminar entitled “Dissecting human antibody responses: useful, basic and surprising findings”. Dr. Lanzavecchia gave a wonderful talk and met with both trainees and faculty throughout his visit. This was the first seminar in the new Infectious Disease and Human Health Series, which is organized by GIVI, HPMI, QBI and BioFulcrum II.
Archives: Lab News
Ott Lab news stories
Sarah McMahon Receives TRDRP Pre-doctoral Fellowship
Congrats to Sarah McMahon who was recently awarded the Tobacco-related Disease Research Program (TRDRP) fellowship to study the role of NF-kB acetylation in models of therapeutic resistance in non-small cell lung cancer.
Sarah McMahon presents her work on NF-kB acetylation at the FASEB Meeting in Lisbon
Sarah recently presented her work at the 2019 FASEB meeting on Protein Acetylation in Disease in Lisbon, Portugal. She gave a phenomenal talk on her work titled, “Regulatory Role for NF-kB/RelA K310 Acetylation Identified In Vivo by a CRISPR Knock-in Approach”, and was a recipient of the “Best Poster” award.
Camille Simoneau gives talk at BayViro 2019
Ott Lab graduate student Camille Simoneau spoke at the 9th Annual Bay Area Symposium on Viruses, on June 7, 2019. Camille’s talk was titled “Modeling CB8+ T cell responses against liver infection with 3D organoids”, and she was one of only two graduate students chosen to give a talk at the event.
Great job, Camille!
Nathan Meyers presents at UCSF Mini-Symposium
Ott Lab postdoctoral scholar Nathan Meyers gave a talk entitled “Hepatitis C virus infects and perturbs liver stem cells” at the UCSF Mini-Symposium on Liver Stem Cells on May 30, 2019. The Mini-Symposium was part of the UCSF Liver Center’s annual programming, and included talks from researchers at Gladstone, UCSF, and Stanford University.
Great job, Nathan!
Dr. Melanie Ott receives Merit Award from NIH
Dr. Melanie Ott was nominated for and accepted an NIH Merit Award for her R01 “Role of Factor Acetylation in the Regulation of HIV transcription”. Merit awards enable NIH Institutes to give investigators with stellar records of research accomplishment a five-year award with the possibility of extending the initial award for up to five additional years without undergoing another IRG peer review.
Congratulations, Melanie!
Kristoffer Leon awarded the Ruth L. Kirschstein National Research Service Award
Kristoffer Leon, a graduate student in the Ott Lab, has been awarded the Ruth L. Kirschstein National Research Service Award for his project ‘Understanding the Role of RNA Surveillance Mechanisms in Neuropathogenesis during Zika Virus Infection’. This is an F31 that will help Kris fund his education and research.
Congrats, Kris!
The Ott Lab shares research at the 2019 Gladstone Scientific Retreat
This year at Gladstone’s Scientific Retreat, several members of the Ott Lab presented their research. Postdoctoral scholar Nathan Meyers gave a talk entitled “HCV Infects and Perturbs Liver Stem Cells”, which received great interest from Gladstone colleagues. Lab members Jennifer Hayashi, Camille Simoneau, Parinaz Fozouni, Albert Vallejo-Gracia, Kristoffer Leon, and Sarah McMahon presented posters, with Parinaz winning a ‘Best Poster’ award.
Congrats, Parinaz, and great job to everyone who presented!
Ott Lab Alumni Achieves Graduate School Success
Former Ott Lab intern Musette Caldera has been accepted to San Francisco State’s Masters Program in Cell and Molecular Biology. Musette was also awarded the NIH Bridges to PhD Fellowship. She will begin her studies this coming Fall 2019.
Congrats, Musette!
The Ott Lab gets exciting grant news
The Ott Lab, in collaboration with Drs Niren Murthy, and Nir Yusef at UC Berkeley as well as Dr. Steven Deeks at UCSF, was awarded an R61 grant by the National Institute of Health’s National Institute on Drug Abuse (NIDA). This grant will enable the Ott Lab to study primary latently infected T cells isolated from aviremic HIV-infected drug users using single-cell RNA-Seq and CRISPR technology.
In more good news, the Ott Lab’s recent R01 renewal ranked in the 3rd percentile during review at NIAID.